Overview

Voltaren Emulgel 2% Acute Ankle Sprain Non Inferiority Study

Status:
Completed
Trial end date:
2020-11-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of diclofenac diethylamine 2.32 percent (%) gel applied twice daily versus diclofenac diethylamine 1.16% gel applied four times daily for 7 days in participants with acute ankle sprain.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Diclofenac